Gianluca Fossati
0000-0002-0060-5822
Publication & Citation Trends
Publications
0 total
Abstract 2839: Inhibiting both Class IIb HDACs is superior to isoform-specific inhibition for improved antitumor immune response
Cited by 0
Semantic Scholar
Abstract 1758: Targeted DNA damage through SSTR2: Preclinical development of a novel peptide-drug conjugate for neuroendocrine tumors
Cited by 0
Semantic Scholar
Abstract 7058: Highly selective HDAC6 inhibitors: Are they the answer for immunomodulation.
Cited by 0
Semantic Scholar
Givinostat inhibits in vitro differentiation of cardiac fibroadipogenic precursors from a mouse model of arrhythmogenic cardiomyopathy.
Cited by 1
Semantic Scholar
Correction: HDAC6 inhibition by ITF3756 modulates PD-L1 expression and monocyte phenotype: insights for a promising immune checkpoint blockade co-treatment therapy
Cited by 3
Semantic Scholar
HDAC6 inhibition by ITF3756 modulates PD-L1 expression and monocyte phenotype: insights for a promising immune checkpoint blockade co-treatment therapy
Cited by 4
Semantic Scholar
Abstract 6176: Selective HDAC6 inhibitor ITF3756 induces IL-2 production and CD4 and NK cells activation in MLR assay
Cited by 0
Semantic Scholar
Abstract 4586: ITF3756 increases NKG2D expression and cytotoxic activity of activated human CD8 T cells
Cited by 0
Semantic Scholar
Research Topics
Histone Deacetylase Inhibitors Research
(41)
Protein Degradation and Inhibitors
(21)
Peptidase Inhibition and Analysis
(20)
Cell Adhesion Molecules Research
(15)
Heat shock proteins research
(12)
Affiliations
St George's Hospital
Howard Hughes Medical Institute
University of Liverpool
University of Liège
St George's, University of London